Bcl-2 inhibition to overcome memory cell barriers in transplantation

American Journal of Transplantation

Volumn 14, Issue 2, 2014, Pages 333-342

  Cippa P E ^a,b   Gabriel, S S ^a,b   Kraus, A K ^a,b   Chen, J ^a,b   Wekerle, T ^c   Guimezanes, A ^d   Wuthrich R P ^a,b   Fehr, T ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

ABT 737; apoptosis; Bcl 2; memory T cells; tolerance; transplantation

Indexed keywords

4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; PROTEIN BCL 2; PROTEIN BCL XL; RNA 18S; T LYMPHOCYTE RECEPTOR; ABT-737; BIPHENYL DERIVATIVE; MESSENGER RNA; NITROPHENOL; PIPERAZINE DERIVATIVE; PROTEIN BCL X; SULFONAMIDE;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE MARROW TRANSPLANTATION; CELL VIABILITY; CELLULAR IMMUNITY; CHIMERA; CONTROLLED STUDY; DRUG TARGETING; FLUORESCENCE ACTIVATED CELL SORTING; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; MEMORY T LYMPHOCYTE; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN TRANSPLANTATION; SPLEEN CELL; ALLOTRANSPLANTATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; DBA MOUSE; DRUG EFFECTS; FLOW CYTOMETRY; GENETICS; GRAFT SURVIVAL; HISTOCOMPATIBILITY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; BIPHENYL COMPOUNDS; BLOTTING, WESTERN; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; FLOW CYTOMETRY; GRAFT SURVIVAL; IMMUNE TOLERANCE; IMMUNOLOGIC MEMORY; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; NITROPHENOLS; PIPERAZINES; PROTO-ONCOGENE PROTEINS C-BCL-2; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN TRANSPLANTATION; SULFONAMIDES; T-LYMPHOCYTES; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 84893344520     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12554     Document Type: Article

References (34)

1. Nadazdin O, Boskovic S, Murakami T, et al. Host alloreactive memory T cells influence tolerance to kidney allografts in nonhuman primates. Sci Transl Med 2011; 3: 86ra51.
2. McElhaney JE, Effros RB., Immunosenescence: What does it mean to health outcomes in older adults ? Curr Opin Immunol 2009; 21: 418-424.
3. den Braber I, Mugwagwa T, Vrisekoop N, et al. Maintenance of peripheral naive T cells is sustained by thymus output in mice but not humans. Immunity 2012; 36: 288-297.
4. London CA, Lodge MP, Abbas AK., Functional responses and costimulator dependence of memory CD4+ T cells. J Immunol 2000; 164: 265-272.
5. Yang J, Brook MO, Carvalho-Gaspar M, et al. Allograft rejection mediated by memory T cells is resistant to regulation. Proc Natl Acad Sci USA 2007; 104: 19954-19959.
6. Adams AB, Williams MA, Jones TR, et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003; 111: 1887-1895.
7. Pearl JP, Parris J, Hale DA, et al. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant 2005; 5: 465-474.
8. Weaver TA, Charafeddine AH, Agarwal A, et al. Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates. Nat Med 2009; 15: 746-749.
9. Badell IR, Russell MC, Thompson PW, et al. LFA-1-specific therapy prolongs allograft survival in rhesus macaques. J Clin Invest 2010; 120: 4520-4531.
10. Pellegrini M, Belz G, Bouillet P, Strasser A., Shutdown of an acute T cell immune response to viral infection is mediated by the proapoptotic Bcl-2 homology 3-only protein Bim. Proc Natl Acad Sci USA 2003; 100: 14175-14180.
11. Sabbagh L, Srokowski CC, Pulle G, et al. A critical role for TNF receptor-associated factor 1 and Bim down-regulation in CD8 memory T cell survival. Proc Natl Acad Sci USA 2006; 103: 18703-18708.
12. Wojciechowski S, Tripathi P, Bourdeau T, et al. Bim/Bcl-2 balance is critical for maintaining naive and memory T cell homeostasis. J Exp Med 2007; 204: 1665-1675.
13. Wensveen FM, van Gisbergen KP, Derks IA, et al. Apoptosis threshold set by Noxa and Mcl-1 after T cell activation regulates competitive selection of high-affinity clones. Immunity 2010; 32: 754-765.
14. Carrington EM, Vikstrom IB, Light A, et al. BH3 mimetics antagonizing restricted prosurvival Bcl-2 proteins represent another class of selective immune modulatory drugs. Proc Natl Acad Sci USA 2010; 107: 10967-10971.
15. Oltersdorf T, Elmore SW, Shoemaker AR, et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 2005; 435: 677-681.
16. Tse C, Shoemaker AR, Adickes J, et al. ABT-263: A potent and orally bioavailable Bcl-2 family inhibitor. Cancer Res 2008; 68: 3421-3428.
17. Wilson WH, O'Connor OA, Czuczman MS, et al. Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: A phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity. Lancet Oncol 2010; 11: 1149-1159.
18. Cippa PE, Kamarashev J, Chen J, et al. Synergistic Bcl-2 inhibition by ABT-737 and cyclosporine A. Apoptosis 2013; 18: 315-323.
19. Cippa PE, Kraus AK, Edenhofer I, et al. The BH3-mimetic ABT-737 inhibits allogeneic immune responses. Transpl Int 2011; 24: 722-732.
20. Cippa PE, Gabriel SS, Chen J, et al. Targeting apoptosis to induce stable mixed hematopoietic chimerism and long-term allograft survival without myelosuppressive conditioning in mice. Blood 2013; 122: 1669-1677.
21. Guimezanes A, Barrett-Wilt GA, Gulden-Thompson P, et al. Identification of endogenous peptides recognized by in vivo or in vitro generated alloreactive cytotoxic T lymphocytes: Distinct characteristics correlated with CD8 dependence. Eur J Immunol 2001; 31: 421-432.
22. Auphan N, Curnow J, Guimezanes A, et al. The degree of CD8 dependence of cytolytic T cell precursors is determined by the nature of the T cell receptor (TCR) and influences negative selection in TCR-transgenic mice. Eur J Immunol 1994; 24: 1572-1577.
23. Buferne M, Luton F, Letourneur F, et al. Role of CD3 delta in surface expression of the TCR/CD3 complex and in activation for killing analyzed with a CD3 delta-negative cytotoxic T lymphocyte variant. J Immunol 1992; 148: 657-664.
24. Manjunath N, Shankar P, Wan J, et al. Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J Clin Invest 2001; 108: 871-878.
25. Lindenmeyer MT, Eichinger F, Sen K, et al. Systematic analysis of a novel human renal glomerulus-enriched gene expression dataset. PloS ONE 2010; 5: e11545.
26. Cippa PE, Kraus AK, Lindenmeyer MT, et al. Resistance to ABT-737 in activated T lymphocytes: Molecular mechanisms and reversibility by inhibition of the calcineurin-NFAT pathway. Cell Death Dis 2012; 3: e299.
27. Markees TG, Phillips NE, Noelle RJ, et al. Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand. Transplantation 1997; 64: 329-335.
28. Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008; 358: 353-361.
29. Scandling JD, Busque S, Shizuru JA, Engleman EG, Strober S., Induced immune tolerance for kidney transplantation. N Engl J Med 2011; 365: 1359-1360.
30. Wekerle T, Kurtz J, Ito H, et al. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med 2000; 6: 464-469.
31. Fehr T, Gaspert A., Antibody-mediated kidney allograft rejection: Therapeutic options and their experimental rationale. Transpl Int 2012; 25: 623-632.
32. Ford ML, Koehn BH, Wagener ME, et al. Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulation. J Exp Med 2007; 204: 299-309.
33. Pilat N, Wekerle T., Transplantation tolerance through mixed chimerism. Nat Rev Nephrol 2010; 6: 594-605.
34. Levesque V, Bardwell PD, Shimizu I, et al. B-Cell-dependent memory T cells impede nonmyeloablative mixed chimerism induction in presensitized mice. Am J Transplant 2011; 11: 2322-2331.